Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study

Sota J;Vitale A;Insalaco A;Sfriso P;Lopalco G;Emmi G;Cattalini M;Manna R;Cimaz R;Priori R;Talarico R;de Marchi G;Frassi M;Gallizzi R;Soriano A;Alessio M;Cammelli D;Maggio MC;Gentileschi S;Marcolongo R;La Torre F;Fabiani C;Colafrancesco S;Ricci F;Galozzi P;Viapiana O;Verrecchia E;Pardeo M;Cerrito L;Cavallaro E;Olivieri AN;Paolazzi G;Vitiello G;Maier A;Silvestri E;Stagnaro C;Valesini G;Mosca M;de Vita S;Tincani A;Lapadula G;Frediani B;De Benedetti F;Iannone F;Punzi L;Salvarani C;Galeazzi M;Angotti R;Messina M;Tosi GM;Rigante D;Cantarini L

;“Working Group” of Systemic Autoinflammatory Diseases of SIR (Italian Society of Rheumatology).

2018